SRTAW vs TXT · rev $248.7M vs P/E 19, rev $7.52B
Strata Critical Medical, Inc. (SRTAW) versus Textron Inc (TXT) — a side-by-side from cached financials, not a winner call.
Strata Critical Medical, Inc. (SRTAW) common stock listed on NASDAQ.
Textron Inc (TXT) is a aerospace & defense company listed on US.
Latest reported SRTAW revenue for 2024-12-31 was $248.7M. Net income was -$27.3M. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. SRTAW currently screens at market cap $0.
Latest reported TXT revenue for 2026-07-04 was $7.52B. Net income was $468.0M. TXT currently screens at market cap $14.85B and trailing P/E 18.5.
SRTAW currently screens at market cap $0. TXT currently screens at market cap $14.85B and trailing P/E 18.5.
Not investment advice. Open the SRTAW and TXT stock pages for the full models.
Not investment advice.